Latest for Halda Therapeutics

Advancing Hope for Prostate Cancer Patients: Johnson & Johnson Acquires Halda for $3.05B
Highlight

Advancing Hope for Prostate Cancer Patients: Johnson & Johnson Acquires Halda for $3.05B

Congrats From Canaan Partners! Canaan congratulates Canaan GP Tim Shannon, Canaan EIR Chris Schade, Halda Scientific founder Craig Crews, and the entire Halda team on the announcement of Halda's acquisition by Johnson & Johnson. 
Taking Hold on Cancer with a New Drug Modality
Highlight

Taking Hold on Cancer with a New Drug Modality

Halda Therapeutics: A biotechnology company that developed a new class of oral cancer medicines designed to selectively kill tumor cells by turning...